According to Merck this was due to very low return on investment at this site, and none of the researcher chemists who created this drug currently work for Merck.
None of the researcher chemists who created this drug currently work for Merck. According to Merck this was due to very low return on investment at this site.
According to Merck this was due to very low return on investment at this site. None of the researcher chemists who created this drug currently work for Merck.
According to Merck this was due to very low return on investment at this site. None of the researcher chemists who created this drug currently work for Merck.